Education
About Us
Working with TipRanks
Follow Us
Solasia Pharma KK (JP:4597)
:4597
Total Valuation
Solasia Pharma KK has a market cap or net worth of ¥7.02B. The enterprise value is ¥6.99B.
Market Cap¥7.02B
Enterprise Value¥6.99B
Share Statistics
Solasia Pharma KK has 219,709,010 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding219,709,010
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Solasia Pharma KK’s return on equity (ROE) is -1.68 and return on invested capital (ROIC) is -164.98%.
Return on Equity (ROE)-1.68
Return on Assets (ROA)-1.43
Return on Invested Capital (ROIC)-164.98%
Return on Capital Employed (ROCE)-1.67
Revenue Per Employee13.74M
Profits Per Employee-84.39M
Employee Count23
Asset Turnover0.23
Inventory Turnover1.02
Valuation Ratios
The current PE Ratio of Solasia Pharma KK is -3.68. Solasia Pharma KK’s PEG ratio is -0.08.
PE Ratio-3.68
PS Ratio0.00
PB Ratio6.19
Price to Fair Value6.19
Price to FCF-6.92
Price to Operating Cash Flow-6.92
PEG Ratio-0.08
Income Statement
In the last 12 months, Solasia Pharma KK had revenue of 316.00M and earned -1.94B in profits. Earnings per share was -9.77.
Revenue316.00M
Gross Profit185.00M
Operating Income-1.95B
Pretax Income-1.96B
Net Income-1.94B
EBITDA-1.91B
Earnings Per Share (EPS)-9.77
Cash Flow
In the last 12 months, operating cash flow was -1.03B and capital expenditures -1.00M, giving a free cash flow of -1.03B billion.
Operating Cash Flow-1.03B
Free Cash Flow-1.03B
Free Cash Flow per Share-4.71
Dividends & Yields
Solasia Pharma KK pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.29
52-Week Price Change23.08%
50-Day Moving Average35.08
200-Day Moving Average41.35
Relative Strength Index (RSI)44.28
Average Volume (3m)4.21M
Important Dates
Solasia Pharma KK upcoming earnings date is May 14, 2025, TBA Not Confirmed.
Last Earnings DateFeb 12, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Solasia Pharma KK as a current ratio of 6.56, with Debt / Equity ratio of 2.16%
Current Ratio6.56
Quick Ratio5.90
Debt to Market Cap0.00
Net Debt to EBITDA0.45
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Solasia Pharma KK has paid 19.00M in taxes.
Income Tax19.00M
Effective Tax Rate>-0.01
Enterprise Valuation
Solasia Pharma KK EV to EBITDA ratio is -3.29, with an EV/FCF ratio of -6.08.
EV to Sales19.91
EV to EBITDA-3.29
EV to Free Cash Flow-6.08
EV to Operating Cash Flow-6.09
Balance Sheet
Solasia Pharma KK has ¥886.00M in cash and marketable securities with ― in debt, giving a net cash position of -¥861.00M billion.
Cash & Marketable Securities¥886.00M
Total Debt―
Net Cash-¥861.00M
Net Cash Per Share-¥3.92
Tangible Book Value Per Share¥5.82
Margins
Gross margin is 18.10%, with operating margin of -617.41%, and net profit margin of -614.24%.
Gross Margin18.10%
Operating Margin-617.41%
Pretax Margin-620.25%
Net Profit Margin-614.24%
EBITDA Margin-605.38%
EBIT Margin-617.09%
Analyst Forecast
The average price target for Solasia Pharma KK is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-48.95%
EPS Growth Forecast-42.99%